Cargando…

A brain proteomic investigation of rapamycin effects in the Tsc1(+/−) mouse model

BACKGROUND: Tuberous sclerosis complex (TSC) is a rare monogenic disorder characterized by benign tumors in multiple organs as well as a high prevalence of epilepsy, intellectual disability and autism. TSC is caused by inactivating mutations in the TSC1 or TSC2 genes. Heterozygocity induces hyperact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wesseling, Hendrik, Elgersma, Ype, Bahn, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540199/ https://www.ncbi.nlm.nih.gov/pubmed/28775826 http://dx.doi.org/10.1186/s13229-017-0151-y

Ejemplares similares

Effects of antiepileptic drugs in a new TSC/mTOR‐dependent epilepsy mouse model
por: Koene, Linda M. C., et al.
Publicado: (2019)

Identifying the temporal electrophysiological and molecular changes that contribute to TSC-associated epileptogenesis
por: Koene, Linda M.C., et al.
Publicado: (2021)

Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders
por: Wesseling, Hendrik, et al.
Publicado: (2014)

Mammalian Target of Rapamycin Complex I (mTORC1) Activity in Ras Homologue Enriched in Brain (Rheb)-Deficient Mouse Embryonic Fibroblasts
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

Stochastic Model of Tsc1 Lesions in Mouse Brain
por: Prabhakar, Shilpa, et al.
Publicado: (2013)

Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in Tsc-1-Suppressed Brain
por: Cox, Rebecca L., et al.
Publicado: (2018)

Correction: Stochastic Model of Tsc1 Lesions in Mouse Brain
por: Prabhakar, Shilpa, et al.
Publicado: (2013)

TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity
por: Liang, Mei-Chih, et al.
Publicado: (2009)

Assessment of Response of Kidney Tumors to Rapamycin and Atorvastatin in Tsc1(+/−) Mice
por: Shen, Ming Hong, et al.
Publicado: (2017)

Proteomic Enrichment Analysis of Psychotic and Affective Disorders Reveals Common Signatures in Presynaptic Glutamatergic Signaling and Energy Metabolism
por: Gottschalk, Michael G., et al.
Publicado: (2015)

Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells
por: Himes, Blanca E., et al.
Publicado: (2018)

MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)
por: Trindade, Anil J., et al.
Publicado: (2013)

The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits
por: Hoogeveen-Westerveld, Marianne, et al.
Publicado: (2012)

Primary TSC2(-/meth) Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model
por: Bernardelli, Clara, et al.
Publicado: (2022)

Induction by rapamycin and proliferation‑promoting activity of Hspb1 in a Tsc2‑deficient cell line
por: Kitano, Takayuki, et al.
Publicado: (2023)

Enhanced Transmission at the Calyx of Held Synapse in a Mouse Model for Angelman Syndrome
por: Wang, Tiantian, et al.
Publicado: (2018)

PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis Complex
por: Alves, Maria M., et al.
Publicado: (2015)

In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome
por: Wang, Tiantian, et al.
Publicado: (2015)

Targeted Multiplexed Selected Reaction Monitoring Analysis Evaluates Protein Expression Changes of Molecular Risk Factors for Major Psychiatric Disorders
por: Wesseling, Hendrik, et al.
Publicado: (2014)

A novel mouse model of tuberous sclerosis complex (TSC): eye-specific Tsc1-ablation disrupts visual-pathway development
por: Jones, Iwan, et al.
Publicado: (2015)

Tumor Suppressors TSC1 and TSC2 Differentially Modulate Actin Cytoskeleton and Motility of Mouse Embryonic Fibroblasts
por: Goncharova, Elena A., et al.
Publicado: (2014)

Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome
por: Sonzogni, Monica, et al.
Publicado: (2020)

Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse
por: Way, Sharon W., et al.
Publicado: (2009)

UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
por: Elgersma, Ype, et al.
Publicado: (2021)

Correction: Tumor Suppressors TSC1 and TSC2 Differentially Modulate Actin Cytoskeleton and Motility of Mouse Embryonic Fibroblasts
Publicado: (2015)

Multidimensional analysis of behavior predicts genotype with high accuracy in a mouse model of Angelman syndrome
por: Tanas, Joseph K., et al.
Publicado: (2022)

Brain Proteomic Profiling in Intractable Epilepsy Caused by TSC1 Truncating Mutations: A Small Sample Study
por: Liu, Yi-Dan, et al.
Publicado: (2020)

Tsc2 mutation rather than Tsc1 mutation dominantly causes a social deficit in a mouse model of tuberous sclerosis complex
por: Kashii, Hirofumi, et al.
Publicado: (2023)

Evidence for population variation in TSC1 and TSC2 gene expression
por: Jentarra, Garilyn M, et al.
Publicado: (2011)

The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome
por: Viho, Eva M. G., et al.
Publicado: (2022)

Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing
por: Tyburczy, Magdalena E., et al.
Publicado: (2015)

Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2
por: Kwiatkowski, David J, et al.
Publicado: (2015)

Analysis of the TSC1and TSC2genes in sporadic renal cell carcinomas
por: Parry, L, et al.
Publicado: (2001)

Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM)
por: Liu, Jie, et al.
Publicado: (2019)

MEK inhibition ameliorates social behavior phenotypes in a Spred1 knockout mouse model for RASopathy disorders
por: Borrie, Sarah C., et al.
Publicado: (2021)

Neurovascular Development in Pten and Tsc2 Mouse Mutants
por: Dusing, Mary, et al.
Publicado: (2023)

Mechanisms underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from other RASopathy mouse models
por: Schreiber, Jadwiga, et al.
Publicado: (2017)

Drosophila yakuba – Tsc1
por: Lose, Bailey, et al.
Publicado: (2021)

Drosophila yakuba – Tsc1
por: Lose, Bailey, et al.
Publicado: (2021)

Germline mutation of TSC1 or TSC2 gene in Chinese patients with bilateral renal angiomyolipomas and mutation spectrum of Chinese TSC patients
por: Jiangyi, Wang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2iban9n0nukgv81ls6ife5h2ju